Publication | Closed Access
Population pharmacokinetics and exposure–response of trametinib, a MEK inhibitor, in patients with BRAF V600 mutation-positive melanoma
54
Citations
16
References
2016
Year
MedicineMelanomaPathologyPopulation PharmacokineticsDermatologyMek InhibitorOncologyRadiation OncologyMolecular OncologySkin Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1